| Product NDC: | 66116-471 |
| Proprietary Name: | Triamcinolone Acetonide |
| Non Proprietary Name: | Triamcinolone Acetonide |
| Active Ingredient(s): | 55 ug/1 & nbsp; Triamcinolone Acetonide |
| Administration Route(s): | NASAL |
| Dosage Form(s): | SPRAY, METERED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 66116-471 |
| Labeler Name: | MedVantx, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078104 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110406 |
| Package NDC: | 66116-471-55 |
| Package Description: | 1 BOTTLE, SPRAY in 1 CARTON (66116-471-55) > 120 SPRAY, METERED in 1 BOTTLE, SPRAY |
| NDC Code | 66116-471-55 |
| Proprietary Name | Triamcinolone Acetonide |
| Package Description | 1 BOTTLE, SPRAY in 1 CARTON (66116-471-55) > 120 SPRAY, METERED in 1 BOTTLE, SPRAY |
| Product NDC | 66116-471 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Triamcinolone Acetonide |
| Dosage Form Name | SPRAY, METERED |
| Route Name | NASAL |
| Start Marketing Date | 20110406 |
| Marketing Category Name | ANDA |
| Labeler Name | MedVantx, Inc. |
| Substance Name | TRIAMCINOLONE ACETONIDE |
| Strength Number | 55 |
| Strength Unit | ug/1 |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |